G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis

[1]  T. Nicolai,et al.  Intensivmedizinische Therapie infektiöser Komplikationen in der pädiatrischen Hämatologie und Onkologie , 2005 .

[2]  H. Heuft,et al.  A dose‐response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection , 2005, Transfusion.

[3]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[4]  J. Klastersky,et al.  Initial empirical antibiotic therapy for neutropenic fever: Analysis of the causes of death , 1996, Supportive Care in Cancer.

[5]  T. Nicolai,et al.  [Management of septic shock and acquired respiratory distress syndrome in pediatric cancer patients]. , 2005, Klinische Padiatrie.

[6]  Michael A Briones,et al.  Granulocyte transfusion: revisited. , 2003, Current hematology reports.

[7]  J. Cornish,et al.  The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation , 2003, British journal of haematology.

[8]  R. Alaggio,et al.  Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience , 2003, Supportive Care in Cancer.

[9]  É. Azoulay,et al.  Improved survival of critically ill cancer patients with septic shock , 2003, Intensive Care Medicine.

[10]  S. Burdach,et al.  Die wachsende Bedeutung der pädiatrischen Intensivstation in der Behandlung onkologischer Patienten - Erfahrungen über 7 Jahre , 2003 .

[11]  S. Pon,et al.  Mortality Rates in Pediatric Septic Shock with and without Multiple Organ System Failure Methods and Materials , 2022 .

[12]  M. Eyrich,et al.  Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation , 2003, British journal of haematology.

[13]  P. Veys,et al.  Outcome of children requiring admission to an intensive care unit after bone marrow transplantation* , 2003, Critical care medicine.

[14]  A. Engert,et al.  Granulocyte Transfusion Therapy for Treatment of Infections after Cytotoxic Chemotherapy , 2003, Oncology Research and Treatment.

[15]  D. Liang.  The Role of Colony-Stimulating Factors and Granulocyte Transfusion in Treatment Options for Neutropenia in Children with Cancer , 2003, Paediatric drugs.

[16]  S. Burdach,et al.  [Oncology patients in a pediatric intensive care unit--a 7-year experience]. , 2003, Klinische Padiatrie.

[17]  S. Pittalis,et al.  Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases , 2003, Supportive Care in Cancer.

[18]  D. Weisdorf,et al.  Is it time for a new look at granulocyte transfusions? , 2002, Transfusion.

[19]  K. Welte,et al.  Efficacy and Safety of G-CSF Mobilized Granulocyte Transfusions in Four Neutropenic Children with Sepsis and Invasive Fungal Infection , 2002, Infection.

[20]  H. Kim,et al.  Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections , 2001, Leukemia.

[21]  M. Boeckh,et al.  Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. , 2000, Blood.

[22]  U. Göbel,et al.  Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children , 2000, Bone Marrow Transplantation.

[23]  T. Klingebiel,et al.  Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients , 1999, British journal of haematology.

[24]  H. Steinert,et al.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. , 1998, Blood.

[25]  S. Chanock,et al.  Controversies in the treatment of neutropenia in cancer patients , 1998, Current opinion in hematology.

[26]  M. Paesmans,et al.  A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies , 1997, British journal of haematology.

[27]  N. Scarpato,et al.  Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. , 1997, Haematologica.

[28]  E. Anaissie,et al.  Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection , 1995, Journal of clinical apheresis.

[29]  J. McCullough,et al.  Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation , 1994, Transfusion.